Publications by authors named "Marko Maringer"

Claim this Profile
S
Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic mice.
Sabina Eigenbrod, Petra Frick, Uwe Bertsch, Gerda Mitteregger-Kretzschmar, Janina Mielke, Marko Maringer

PLoS One· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel drug targets in cell wall biosynthesis exploited by gene disruption in Pseudomonas aeruginosa.
Ayssar A Elamin, Susanne Steinicke, Wulf Oehlmann, Yvonne Braun, Hanaa Wanas, Marko Maringer

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric competitive inhibitors of the glucose-1-phosphate thymidylyltransferase (RmlA) from Pseudomonas aeruginosa.
Magnus S Alphey, Lisa Pirrie, Leah S Torrie, Wassila Abdelli Boulkeroua, Mary Gardiner, Marko Maringer

ACS Chem Biol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydrodipicolinate N-succinyltransferase and dihydrodipicolinate synthase from Pseudomonas aeruginosa: structure analysis and gene deletion.
Robert Schnell, Wulf Oehlmann, Tatyana Sandalova, Yvonne Braun, Carmen Huck, Marko Maringer

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of tTS-H4: a novel transcriptional repressor that is compatible with the reverse tetracycline-controlled TET-ON system.
Ernesto Bockamp, Cerstin Christel, Dorothe Hameyer, Andriy Khobta, Marko Maringer

J Gene Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.
Ernesto Bockamp, Cecilia Antunes, Marko Maringer, Rosario Heck, Katrin Presser

Blood· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unaltered prion protein cleavage in plasminogen-deficient mice.
Kathrin Barnewitz, Marko Maringer, Gerda Mitteregger, Armin Giese, Uwe Bertsch

Neuroreport· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
Tatjana M Trost, Ekkehart U Lausch, Stephan A Fees, Steffen Schmitt, Thorsten Enklaar, Marko Maringer

Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Of mice and models: improved animal models for biomedical research.
Ernesto Bockamp, Marko Maringer, Christian Spangenberg, Stephan Fees, Stuart Fraser

Physiol Genomics· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis